MedPath

A Single-Case Experimental Study in the combination of cognitive-behavioral therapy and pharmacotherapy in smoking cessation, a review of the literature

Phase 1
Conditions
In this study&#44
the informed consent was obtained and the Whole process was carried out based on the latest version of the Declaration of Helsinki.
cognitive&#45
behavioral therapy&#44
pharmacotherapy&#44
smoking cessation&#44
Bupropion
Registration Number
TCTR20180329004
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated (Halted Prematurely)
Sex
Female
Target Recruitment
1
Inclusion Criteria

A Single-Case Experimental Study

Exclusion Criteria

A Single-Case Experimental Study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath